Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T21945 | Target Info | |||
Target Name | Norepinephrine transporter (NET) | ||||
Synonyms |
Solute carrier family 6 member 2; Sodium-dependent noradrenaline transporter; SLC6A2; NET1; NET; NAT1
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | SLC6A2 | ||||
Biochemical Class | Neurotransmitter:sodium symporter | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Serotonin transporter (SERT) | Successful Target | ||||
UniProt ID | SC6A4_HUMAN | |||||
Gene Name | SLC6A4 | |||||
Synonyms |
Solute carrier family 6 member 4; HTT; 5HTT; 5HT transporter
Click to Show/Hide
|
|||||
Representative Drug(s) | Duloxetine | Drug Info | Ki = 0.24 nM | Click to Show More | [1] | |
2 | Imipramine | Drug Info | Ki = 0.52 nM | [3] | ||
3 | METHYLENEDIOXYMETHAMPHETAMINE | Drug Info | Ki = 0.73 nM | [4] | ||
4 | Drug Info | Ki = 4.3 nM | [8] | |||
5 | Venlafaxine | Drug Info | Ki = 11 nM | [1] | ||
6 | Amitifadine | Drug Info | IC50 = 12.3 nM | [10] | ||
7 | Desipramine | Drug Info | Ki = 20 nM | [12] | ||
8 | Milnacipran | Drug Info | Ki = 22 nM | [13] | ||
9 | Cocaine | Drug Info | Ki = 45 nM | [16] | ||
10 | Mazindol | Drug Info | Ki = 45 nM | [11] | ||
11 | Atomoxetine | Drug Info | IC50 = 48 nM | [17] | ||
12 | Drug Info | IC50 ~ 100 nM | [7] | |||
13 | Bicifadine | Drug Info | IC50 = 117 nM | [20] | ||
14 | Levomilnacipran | Drug Info | IC50 = 320 nM | [24] | ||
Co-Target Name | Dopamine transporter (DAT) | Successful Target | ||||
UniProt ID | SC6A3_HUMAN | |||||
Gene Name | SLC6A3 | |||||
Synonyms |
Solute carrier family 6 member 3; Sodium-dependent dopamine transporter; DAT1; DAT; DA transporter
Click to Show/Hide
|
|||||
Representative Drug(s) | Desipramine | Drug Info | Ki = 0.49 nM | Click to Show More | [2] | |
2 | Mazindol | Drug Info | IC50 = 13 nM | [11] | ||
3 | Cocaine | Drug Info | Ki = 32 nM | [15] | ||
4 | Amitifadine | Drug Info | Ki = 79.43 nM | [18] | ||
5 | Duloxetine | Drug Info | Ki = 240 nM | [23] | ||
6 | Drug Info | Ki = 441 nM | [25] | |||
7 | Venlafaxine | Drug Info | Ki ~ 890 nM | [1] | ||
8 | METHYLENEDIOXYMETHAMPHETAMINE | Drug Info | Ki = 897 nM | [26] | ||
9 | Bicifadine | Drug Info | IC50 = 910 nM | [20] | ||
Co-Target Name | Histamine H1 receptor (H1R) | Successful Target | ||||
UniProt ID | HRH1_HUMAN | |||||
Gene Name | HRH1 | |||||
Synonyms |
HH1R; H1R
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | Ki = 1.12 nM | Click to Show More | [5] | ||
2 | Maprotiline | Drug Info | Ki = 1.67 nM | [5] | ||
3 | Imipramine | Drug Info | IC50 = 27 nM | [14] | ||
Co-Target Name | 5-HT 2A receptor (HTR2A) | Successful Target | ||||
UniProt ID | 5HT2A_HUMAN | |||||
Gene Name | HTR2A | |||||
Synonyms |
Serotonin receptor 2A; HTR2; 5-hydroxytryptamine receptor 2A; 5-HT-2A; 5-HT-2
Click to Show/Hide
|
|||||
Representative Drug(s) | Amoxapine | Drug Info | Ki = 1.77 nM | Click to Show More | [6] | |
2 | Imipramine | Drug Info | Ki = 94 nM | [19] | ||
3 | Desipramine | Drug Info | Ki = 160 nM | [21] | ||
Co-Target Name | Neuronal acetylcholine receptor alpha-3/beta-4 (CHRNA3/B4) | Successful Target | ||||
UniProt ID | ACHA3_HUMAN-ACHB4_HUMAN | |||||
Gene Name | CHRNA3-CHRNB4 | |||||
Synonyms |
Neuronal acetylcholine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | IC50 = 1.8 nM | [7] | |||
Co-Target Name | Voltage-gated potassium channel Kv11.1 (KCNH2) | Successful Target | ||||
UniProt ID | KCNH2_HUMAN | |||||
Gene Name | KCNH2 | |||||
Synonyms |
hERG1; hERG-1; Voltage-gated potassium channel subunit Kv11.1; Potassium voltage-gated channel subfamily H member 2; HERG K+ channel; HERG; H-ERG; Ether-a-go-go-related protein 1; Ether-a-go-go-related gene potassium channel 1; Ether-a-go-go related protein 1; Ether-a-go-go related gene potassium channel 1; Eag related protein 1; Eag homolog; ERG-1; ERG
Click to Show/Hide
|
|||||
Representative Drug(s) | Cocaine | Drug Info | IC50 = 4.4 nM | [9] | ||
Co-Target Name | Neuronal acetylcholine receptor alpha-4/beta-2 (CHRNA4/B2) | Successful Target | ||||
UniProt ID | ACHA4_HUMAN-ACHB2_HUMAN | |||||
Gene Name | CHRNA4-CHRNB2 | |||||
Synonyms |
CHRN; nAChR
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | IC50 = 12 nM | [7] | |||
Co-Target Name | Dopamine D4 receptor (D4R) | Successful Target | ||||
UniProt ID | DRD4_HUMAN | |||||
Gene Name | DRD4 | |||||
Synonyms |
DRD4; D(2C)D(4) dopamine receptor dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Amoxapine | Drug Info | Ki = 34 nM | [6] | ||
Co-Target Name | Dopamine D1 receptor (D1R) | Successful Target | ||||
UniProt ID | DRD1_HUMAN | |||||
Gene Name | DRD1 | |||||
Synonyms |
D(1A) dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | Ki = 89 nM | Click to Show More | [5] | ||
2 | Maprotiline | Drug Info | Ki = 402 nM | [5] | ||
Co-Target Name | 5-HT 2C receptor (HTR2C) | Successful Target | ||||
UniProt ID | 5HT2C_HUMAN | |||||
Gene Name | HTR2C | |||||
Synonyms |
Serotonin receptor 2C; HTR1C; 5HT-1C; 5-hydroxytryptamine receptor 2C; 5-hydroxytryptamine receptor 1C; 5-HTR2C; 5-HT2C receptor; 5-HT2C; 5-HT1C; 5-HT-2C; 5-HT-1C
Click to Show/Hide
|
|||||
Representative Drug(s) | Imipramine | Drug Info | Ki = 160 nM | [19] | ||
Co-Target Name | Dopamine D5 receptor (D5R) | Successful Target | ||||
UniProt ID | DRD5_HUMAN | |||||
Gene Name | DRD5 | |||||
Synonyms |
Dopamine receptor 5; DRD5; D1beta dopamine receptor; D(5)D(1B) dopamine receptor dopamine receptor; D(5) dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | Ki = 170 nM | Click to Show More | [5] | ||
2 | Maprotiline | Drug Info | Ki = 429 nM | [5] | ||
Co-Target Name | Dopamine D2 receptor (D2R) | Successful Target | ||||
UniProt ID | DRD2_HUMAN | |||||
Gene Name | DRD2 | |||||
Synonyms |
Dopamine receptor 2; D(2) dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | Ki = 196 nM | Click to Show More | [5] | ||
2 | Imipramine | Drug Info | IC50 = 410 nM | [14] | ||
3 | Maprotiline | Drug Info | Ki = 665 nM | [5] | ||
Co-Target Name | Dopamine D3 receptor (D3R) | Successful Target | ||||
UniProt ID | DRD3_HUMAN | |||||
Gene Name | DRD3 | |||||
Synonyms |
D(3) dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | Ki = 206 nM | Click to Show More | [5] | ||
2 | Maprotiline | Drug Info | Ki = 504 nM | [5] | ||
Co-Target Name | 5-HT 1A receptor (HTR1A) | Successful Target | ||||
UniProt ID | 5HT1A_HUMAN | |||||
Gene Name | HTR1A | |||||
Synonyms |
Serotonin receptor 1A; G-21; ADRBRL1; ADRB2RL1; 5-hydroxytryptamine receptor 1A; 5-HT1A receptor; 5-HT1A; 5-HT-1A
Click to Show/Hide
|
|||||
Representative Drug(s) | Amoxapine | Drug Info | Ki = 221 nM | [6] | ||
Co-Target Name | Opioid receptor sigma 1 (OPRS1) | Successful Target | ||||
UniProt ID | SGMR1_HUMAN | |||||
Gene Name | SIGMAR1 | |||||
Synonyms |
hSigmaR1; Sigma1R; Sigma1-receptor; Sigma non-opioid intracellular receptor 1; Sigma 1-type opioid receptor; SRBP; SR31747-binding protein; SR31747 binding protein 1; SR-BP; SIG-1R; Opioid receptor, sigma 1, isoform 1; OPRS1 protein; Aging-associated gene 8 protein; AAG8
Click to Show/Hide
|
|||||
Representative Drug(s) | Mazindol | Drug Info | IC50 = 234.42 nM | [22] | ||
Co-Target Name | Debrisoquine 4-hydroxylase (CYP2D6) | Successful Target | ||||
UniProt ID | CP2D6_HUMAN | |||||
Gene Name | CYP2D6 | |||||
Synonyms |
P450-DB1; Cytochrome P450-DB1; Cytochrome P450 2D6; CYPIID6; CYP2DL1
Click to Show/Hide
|
|||||
Representative Drug(s) | Duloxetine | Drug Info | IC50 = 1000 nM | [27] | ||
Co-Target Name | Albendazole monooxygenase (CYP3A4) | Clinical trial Target | ||||
UniProt ID | CP3A4_HUMAN | |||||
Gene Name | CYP3A4 | |||||
Synonyms |
Taurochenodeoxycholate 6-alpha-hydroxylase; Quinine 3-monooxygenase; P450-PCN1; Nifedipine oxidase; NF-25; HLp; Cytochrome P450-PCN1; Cytochrome P450 NF-25; Cytochrome P450 HLp; Cytochrome P450 3A4; Cytochrome P450 3A3; CYPIIIA4; CYPIIIA3; CYP3A3; Albendazole sulfoxidase; Albendazole monooxygenase (sulfoxide-forming); 1,8-cineole 2-exo-monooxygenase
Click to Show/Hide
|
|||||
Representative Drug(s) | Duloxetine | Drug Info | IC50 = 440 nM | [28] | ||
Co-Target Name | 5-HT 7 receptor (HTR7) | Clinical trial Target | ||||
UniProt ID | 5HT7R_HUMAN | |||||
Gene Name | HTR7 | |||||
Synonyms |
Serotonin receptor 7; 5HT7; 5-hydroxytryptamine receptor 7; 5-HT7 receptor; 5-HT7; 5-HT-X; 5-HT-7
Click to Show/Hide
|
|||||
Representative Drug(s) | Amoxapine | Drug Info | Ki = 500 nM | [29] | ||
Co-Target Name | Voltage-gated sodium channel alpha Nav1.7 (SCN9A) | Clinical trial Target | ||||
UniProt ID | SCN9A_HUMAN | |||||
Gene Name | SCN9A | |||||
Synonyms |
hNE-Na; Voltage-gated sodium channel subunit alpha Nav1.7; Sodium channel proteintype IX subunit alpha; Sodium channel proteintype 9 subunit alpha; Sodium channel protein type IX subunit alpha; Sodium channel protein type 9 subunit alpha; Peripheral sodium channel 1; PN1; Neuroendocrine sodium channel; NENA
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | IC50 = 1000 nM | [30] | |||
Co-Target Name | Histamine H3 receptor (H3R) | Clinical trial Target | ||||
UniProt ID | HRH3_HUMAN | |||||
Gene Name | HRH3 | |||||
Synonyms |
Histamine receptor 3; HH3R; GPCR97; G-protein coupled receptor 97; G protein-coupled receptor 97
Click to Show/Hide
|
|||||
Representative Drug(s) | Maprotiline | Drug Info | Ki ~ 1000 nM | Click to Show More | [5] | |
2 | Drug Info | Ki ~ 1000 nM | [5] | |||
Co-Target Name | Acetylcholine receptor alpha-1/beta-1/delta/gamma (CHRNA1/CHRNA1/CHRND/CHRNG) | Co-Target | ||||
UniProt ID | ACHA_HUMAN-ACHB_HUMAN-ACHD_HUMAN-ACHG_HUMAN | |||||
Gene Name | CHRNA1-CHRNB1-CHRND-CHRNG | |||||
Representative Drug(s) | Drug Info | IC50 = 7.9 nM | [7] | |||
Co-Target Name | Neuronal acetylcholine receptor alpha4/beta4 (CHRNA4/CHRNB4) | Co-Target | ||||
UniProt ID | ACHA4_HUMAN; ACHB4_HUMAN | |||||
Gene Name | CHRNA4; CHRNB4 | |||||
Representative Drug(s) | Drug Info | IC50 = 15 nM | [7] | |||
Co-Target Name | Solute carrier family 22 member 2 (SLC22A2) | Co-Target | ||||
UniProt ID | S22A2_HUMAN | |||||
Gene Name | SLC22A2 | |||||
Synonyms |
Organic cation transporter 2; hOCT2
Click to Show/Hide
|
|||||
Representative Drug(s) | Imipramine | Drug Info | IC50 = 600 nM | [31] | ||
Co-Target Name | Neuronal acetylcholine receptor alpha3/beta2 (CHRNA3/CHRNB2) | Co-Target | ||||
UniProt ID | ACHA3_HUMAN; ACHB2_HUMAN | |||||
Gene Name | CHRNA3; CHRNB2 | |||||
Representative Drug(s) | Drug Info | IC50 = 1000 nM | [32] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor. ACS Med Chem Lett. 2013 May 7;4(6):560-4. | ||||
REF 2 | Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography. J Med Chem. 2003 Mar 13;46(6):925-35. | ||||
REF 3 | Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds. Eur J Med Chem. 2013 May;63:85-94. | ||||
REF 4 | Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter. Bioorg Med Chem. 2008 Jun 15;16(12):6364-70. | ||||
REF 5 | Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics. Bioorg Med Chem Lett. 2009 Jan 15;19(2):538-42. | ||||
REF 6 | New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. J Med Chem. 2012 Feb 23;55(4):1572-82. | ||||
REF 7 | Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. J Med Chem. 2010 Mar 11;53(5):2204-14. | ||||
REF 8 | The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds. Bioorg Med Chem Lett. 2014 Jan 15;24(2):576-9. | ||||
REF 9 | Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. J Med Chem. 2002 Aug 29;45(18):3844-53. | ||||
REF 10 | Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors. Bioorg Med Chem Lett. 2008 Jul 1;18(13):3682-6. | ||||
REF 11 | Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters. J Med Chem. 2017 Apr 13;60(7):3109-3123. | ||||
REF 12 | Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phen... J Med Chem. 2010 Nov 11;53(21):7869-73. | ||||
REF 13 | Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT. Bioorg Med Chem. 2017 Jan 1;25(1):293-304. | ||||
REF 14 | Polypharmacology-foe or friend? J Med Chem. 2013 Nov 27;56(22):8955-71. | ||||
REF 15 | Synthesis and ligand binding of eta(6)-(2beta-carbomethoxy-3beta-phenyltropane) transition metal complexes. J Med Chem. 1996 Mar 29;39(7):1560-3. | ||||
REF 16 | Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes. J Med Chem. 2005 Nov 17;48(23):7437-44. | ||||
REF 17 | Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors. Bioorg Med Chem Lett. 2008 Sep 15;18(18):4929-31. | ||||
REF 18 | 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor. J Med Chem. 2010 Jul 8;53(13):4989-5001. | ||||
REF 19 | Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA). Bioorg Med Chem Lett. 2004 May 3;14(9):2279-83. | ||||
REF 20 | Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges. J Med Chem. 2018 Mar 22;61(6):2133-65. | ||||
REF 21 | Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene. Bioorg Med Chem Lett. 2001 Mar 12;11(5):655-8. | ||||
REF 22 | Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor. J Med Chem. 1994 Nov 25;37(24):4109-17. | ||||
REF 23 | Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake. Bioorg Med Chem Lett. 2003 Dec 15;13(24):4477-80. | ||||
REF 24 | Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3328-32. | ||||
REF 25 | A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone. Bioorg Med Chem. 2009 Jun 1;17(11):3770-4. | ||||
REF 26 | An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3411-5. | ||||
REF 27 | 4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships. Bioorg Med Chem Lett. 2009 May 15;19(10):2829-34. | ||||
REF 28 | Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors. Bioorg Med Chem Lett. 2014 Aug 1;24(15):3234-7. | ||||
REF 29 | Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). J Med Chem. 2003 Jul 3;46(14):2795-812. | ||||
REF 30 | 3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models. J Med Chem. 2012 Aug 9;55(15):6866-80. | ||||
REF 31 | Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem. 2011 Jul 14;54(13):4548-58. | ||||
REF 32 | Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem. 2005 Jul 28;48(15):4705-45. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.